The effects of secondary prevention after coronary revascularization in Taiwan

Secondary prevention therapy for patients with coronary artery disease using an antiplatelet agent, β-blocker, renin-angiotensin system blocker (RASB), or statin plays an important role in the reduction of coronary events after coronary artery bypass grafting (CABG) surgery or percutaneous coronary...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2019-05, Vol.14 (5), p.e0215811-e0215811
Hauptverfasser:	Feng, Wen-Han, Chu, Chun-Yuan, Hsu, Po-Chao, Lee, Wen-Hsien, Su, Ho-Ming, Lin, Tsung-Hsien, Yen, Hsueh-Wei, Voon, Wen-Chol, Lai, Wen-Ter, Sheu, Sheng-Hsiung
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-antagonists Aged Analysis Angiotensin Angiotensins Balloon angioplasty Cardiology Cardiovascular agents Cardiovascular disease Care and treatment Chronic kidney failure Chronic obstructive pulmonary disease Clopidogrel Codes Cohort Studies Comorbidity Coronary artery Coronary Artery Bypass Coronary artery disease Coronary Artery Disease - surgery Coronary Artery Disease - therapy Coronary heart disease Coronary vessels Data bases Databases, Factual Diabetes Diabetes mellitus Disease prevention Dosage and administration Drugs Female Health insurance Health risks Heart attacks Heart diseases Heart surgery Hospitals Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology Insurance Internal medicine Kidney diseases Male Medical research Medicine Medicine and Health Sciences Middle Aged Mortality National health insurance Online databases Patients Percutaneous Coronary Intervention Platelet aggregation inhibitors Population studies Prescription drugs Prevention Renin Renin-angiotensin system Risk analysis Risk Factors Secondary Prevention Statins Surgery Taiwan Task forces Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!